SVB announced it's acquiring Leerink. Any thoughts on this and what it means for Leerink?
Trending Content - Investment Banking Forum
| +142 | ONLY THESE BANKS OR YOU STRUCK OUT | 37 | 1h |
| +111 | IB Energy Drink Tier List / Ranking | 73 | 1d |
| +59 | Firm Thinks I'm Lying About Offer | 19 | 1h |
| +51 | Feedback for internship first desk at IBD BB - personal fit, "don't be too confident" | 29 | 2d |
| +48 | Indiana University Fraternity Pipelines | 29 | 4h |
| +39 | Stay at Weak Dealflow Team or Lateral? | 12 | 7h |
| +34 | Elite Boutique interview questions | 8 | 9h |
| +32 | Rogo AI | 13 | 3h |
| +30 | Does BofA still pay its associates rat pellets? | 15 | 2d |
| +27 | Suspended for a Year | 11 | 6m |
Career Resources
They basically say it in the press release: " The acquisition will accelerate the growth and geographic reach of Leerink’s offering, while providing SVB with a diverse and growing revenue stream, as well as the opportunity for their collective clients to leverage the broadest set of products and services available."
Leadership isn't moving, there's an employee retention pool for 5 years, and both pursue similar objectives with their clients. What this is really going to impact is their current and future clients. There's going to be a significant increase in capital, as well as a new range of complementary services. Plus SVB works with a wider variety of related sectors than Leerink currently does, meaning there's now an easier in and potential mutual benefits for Leerink's healthcare/medical tool/bio-pharma companies in need of SVB's hardware/software or energy clients. Hopefully, this will massively increase the rate at which their clients are able to develop their P&S.
Here's to improving healthcare/biotech/pharma development.